23andMe back on the auction block after former CEO makes 11th-hour bid

Anne Wojcicki, ex-CEO of the DNA testing firm, put in a $305m bid, upending Regeneron's $256m agreement

The DNA testing company 23andMe is back up for sale, throwing a purchase agreement reached last month into chaos, court filings show.

The board of directors of 23andMe, which filed for bankruptcy in March, had agreed to sell the company and its assets to the pharmaceutical firm Regeneron for $256m after conducting an auction in April. However, the founder and former CEO of the genetics company, Anne Wojcicki, put in a $305m bid through a newly formed non-profit, TTAM Research Institute, after the auction ended and pushed the bankruptcy court to reopen the sale process. She tried to buy the company multiple times during its long decline and bankruptcy but was rejected by the board.